JP2004528810A5 - - Google Patents

Download PDF

Info

Publication number
JP2004528810A5
JP2004528810A5 JP2002532655A JP2002532655A JP2004528810A5 JP 2004528810 A5 JP2004528810 A5 JP 2004528810A5 JP 2002532655 A JP2002532655 A JP 2002532655A JP 2002532655 A JP2002532655 A JP 2002532655A JP 2004528810 A5 JP2004528810 A5 JP 2004528810A5
Authority
JP
Japan
Prior art keywords
fold
cell
nos
seq
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002532655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004528810A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/030732 external-priority patent/WO2002029086A2/en
Publication of JP2004528810A publication Critical patent/JP2004528810A/ja
Publication of JP2004528810A5 publication Critical patent/JP2004528810A5/ja
Pending legal-status Critical Current

Links

JP2002532655A 2000-10-02 2001-10-02 癌組織でディファレンシャルに発現される核酸配列 Pending JP2004528810A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23727100P 2000-10-02 2000-10-02
PCT/US2001/030732 WO2002029086A2 (en) 2000-10-02 2001-10-02 Nucleic acid sequences differentially expressed in cancer tissue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007150552A Division JP2007289196A (ja) 2000-10-02 2007-06-06 癌組織でディファレンシャルに発現される核酸配列

Publications (2)

Publication Number Publication Date
JP2004528810A JP2004528810A (ja) 2004-09-24
JP2004528810A5 true JP2004528810A5 (cg-RX-API-DMAC7.html) 2007-02-15

Family

ID=22893028

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002532655A Pending JP2004528810A (ja) 2000-10-02 2001-10-02 癌組織でディファレンシャルに発現される核酸配列
JP2007150552A Pending JP2007289196A (ja) 2000-10-02 2007-06-06 癌組織でディファレンシャルに発現される核酸配列

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007150552A Pending JP2007289196A (ja) 2000-10-02 2007-06-06 癌組織でディファレンシャルに発現される核酸配列

Country Status (5)

Country Link
US (2) US20040110668A1 (cg-RX-API-DMAC7.html)
EP (1) EP1330543A4 (cg-RX-API-DMAC7.html)
JP (2) JP2004528810A (cg-RX-API-DMAC7.html)
AU (1) AU2001294943A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002029086A2 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7258973B2 (en) 1998-08-31 2007-08-21 Mayo Foundation For Medical Education & Research Method for detecting a differentially expressed sequence
EP1666491A1 (en) * 2000-06-02 2006-06-07 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2002318112B2 (en) 2001-04-10 2007-12-06 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
EP2325335A3 (en) * 2001-09-14 2012-01-25 Clinical Genomics Pty. Ltd Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
US7449548B2 (en) 2001-12-07 2008-11-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
EP2275118A3 (en) 2002-05-29 2011-10-19 DeveloGen Aktiengesellschaft Pancreas-specific proteins
AU2003276494A1 (en) * 2002-06-13 2004-01-23 Regulome Corporation Functional sites
WO2004016733A2 (en) 2002-08-16 2004-02-26 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
US7393950B2 (en) * 2002-08-29 2008-07-01 Hong Kong University Of Science & Technology Antisense oligonucleotides targeted to human CDC45
EP1599498A2 (en) * 2003-03-03 2005-11-30 Genentech, Inc. Compositions and methods for the treatment of systemic lupus erythematosis
WO2005017102A2 (en) * 2003-05-30 2005-02-24 Diadexus, Inc. Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
DE10332854A1 (de) * 2003-07-18 2005-02-17 Universitätsklinikum der Charité der Humboldt-Universität zu Berlin Verwendung des neu-identifizierten humanen Gens 7a5/Prognostin für Tumordiagnostik und Tumortherapie
ATE528397T1 (de) 2003-08-08 2011-10-15 Perseus Proteomics Inc Bei krebs überexprimiertes gen
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US20060134653A1 (en) * 2004-07-28 2006-06-22 Bayer Healthcare Llc Differential expression of genes in microsatellite instability
US8535914B2 (en) * 2005-01-21 2013-09-17 Canon Kabushiki Kaisha Probe, probe set and information acquisition method using the same
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
FR2919061B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
FR2919062B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal.
ES2565512T3 (es) * 2007-07-19 2016-04-05 bioMérieux Procedimiento de ensayo de la proteína de unión a ácidos grasos del hígado, de ACE y de CA19-9 para el diagnóstico in vitro del cáncer colorrectal
FR2919060B1 (fr) * 2007-07-19 2012-11-30 Biomerieux Sa Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal.
FR2919064B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine all pour le diagnostic in vitro du cancer colorectal
FR2919065B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
FR2933773B1 (fr) 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal
WO2010135786A1 (en) * 2009-05-29 2010-12-02 Clinical Genomics Pty. Ltd. A method for diagnosing neoplasms and molecules for use therein
AU2015200751B2 (en) * 2010-03-19 2016-11-10 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors including gastrointestinal and gastric cancer
GB201004551D0 (en) 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
US11136583B2 (en) 2017-01-10 2021-10-05 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
JP6702932B2 (ja) * 2017-12-27 2020-06-03 富士フイルム株式会社 細胞撮像制御装置および方法並びにプログラム

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2135194A1 (en) * 1992-05-22 1993-12-09 Charles L. Bevins Gastrointestinal defensins, cdna sequences and method for the production and use thereof
US5861494A (en) * 1995-06-06 1999-01-19 Human Genome Sciences, Inc. Colon specific gene and protein
US6171816B1 (en) * 1996-08-23 2001-01-09 Human Genome Sciences, Inc. Human XAG-1 polynucleotides and polypeptides
US5837841A (en) * 1996-10-11 1998-11-17 Incyte Pharmaceuticals, Inc. Human Reg protein
WO1998041627A1 (en) * 1997-03-19 1998-09-24 Zymogenetics, Inc. Secreted polypeptides with homology to xenopus cement gland proteins
AU8921598A (en) * 1997-08-29 1999-03-16 Human Genome Sciences, Inc. 29 human secreted proteins
AU1726199A (en) * 1997-12-31 1999-07-19 Chiron Corporation Metastatic cancer regulated gene
US5929033A (en) * 1998-02-10 1999-07-27 Incyte Pharmaceuticals, Inc. Extracellular mucous matrix glycoprotein
DE19817946A1 (de) * 1998-04-17 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Uterus-Normalgewebe
US6262333B1 (en) * 1998-06-10 2001-07-17 Bayer Corporation Human genes and gene expression products
EP1108021A2 (en) * 1998-08-31 2001-06-20 Bayer Corporation Human genes differentially expressed in colorectal cancer
EP1144632A3 (en) * 1998-12-23 2001-11-07 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
EP1265582A2 (en) * 1999-09-29 2002-12-18 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
AU4592601A (en) * 2000-03-21 2001-10-03 Millennium Predictive Medicine Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer

Similar Documents

Publication Publication Date Title
JP2004528810A5 (cg-RX-API-DMAC7.html)
US10344334B2 (en) Method of diagnosing neoplasms
CA2318354A1 (en) Biomarkers and targets for diagnosis, prognosis and management of prostate disease
CA2476892C (en) Mononucleotide repeats microsatellite markers for detecting microsatellite instability
JP2007506426A5 (cg-RX-API-DMAC7.html)
KR20120059648A (ko) 방광암 검출용 소변 표지
ES2599816T3 (es) Métodos relacionados con el gen GLI3 para la detección de cáncer colorrectal
CA2362527A1 (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
JP5769952B2 (ja) Ｅｍｌ４−ａｌｋ融合遺伝子の高感度検出方法
WO1999028506A2 (en) Cancer susceptibility mutations of brca2
JP2005537007A5 (cg-RX-API-DMAC7.html)
US20120039887A1 (en) Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript
US20090011413A1 (en) Method for screening colon cancer cells and gene set used for examination of colon cancer
KR101206029B1 (ko) 대장암 진단용 다중 ｓｎｐ, 그를 포함하는 마이크로어레이및 키트 및 그를 이용한 대장암 진단 방법
JP2004187620A (ja) 腎疾患の疾患マーカーおよびその利用
CN112941179B (zh) 基因在评估口腔鳞癌中的应用
WO2000047765A1 (en) Materials and methods relating to the detection of a cancer cell marker
JP2005528910A5 (cg-RX-API-DMAC7.html)
JPWO2002083899A1 (ja) 癌関連遺伝子
JP2004531241A5 (cg-RX-API-DMAC7.html)
JP2010501162A5 (cg-RX-API-DMAC7.html)
JP2007532142A (ja) 乳がん遺伝子発現バイオマーカー
KR101931614B1 (ko) 칡소의 친자감정용 조성물
JP2011518541A5 (cg-RX-API-DMAC7.html)
JP2007510424A (ja) 分子マーカー